Dianthus Therapeutics | Kapitał Własny I Rezerwy



Equity Capital And Reserves Zmiana Data
Adcock Ingram Holdings ZAR 5.41B 63.09M 2024-06
Alaunos Therapeutics USD 2.72M 1.05M 2024-09
Avita Medical AUD 4.5M 19.42M 2024-12
Celltrion KRW 16.89T 38.11B 2024-09
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Ecofibre AUD 40.97M 10.34M 2024-06
IQVIA Holdings USD 6.07B 900M 2024-12
Kangmei Pharma CNY 7.04B 22.02M 2024-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 581.54M 98.78M 2024-12
Malin Corporation EUR 118.2M 8.7M 2024-06
Medical Developments International AUD 45.73M 29.96M 2024-06
Moderna USD 10.9B 1.03B 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 323.65M 17.66M 2024-12
Organon & Co USD 472M 21M 2024-12
Pharma Mar EUR 208.36M 26.19M 2024-12
Qiagen NV USD 3.57B 37.35M 2024-12
Revvity USD 7.67B 254.83M 2024-12
Sartorius EUR 3.78B 33.4M 2024-09
Sino Biopharmaceutical CNY 31.96B 10.16B 2024-12
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Viatris USD 18.64B 1.16B 2024-12
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12
Zz Pientze Pharmaceu 14.02B 351.74M 2024-09



Dianthus Therapeutics Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.